Skip to main navigation

Back

Menu

Aesthetics
Back Aesthetics
Therapeutics
Back Therapeutics
Investors
Back Investors
LATEST NEWS
Our Latest

May 19, 2020

Revance announces addition of fintech platform for aesthetic practices with acquisition of HintMD All News
Company
Back Company
OUR LATEST
Our Latest

May 19, 2020

Revance announces addition of fintech platform for aesthetic practices with acquisition of HintMD Our Latest
News
Careers
Back Careers

facebook
instagram
twitter
linkedin

7555 Gateway Boulevard
Newark, California 94560

+1 (510) 742-3400

© Copyright 2020

All Rights Reserved

Breadcrumb

Home
Investors
Press releases

Press Releases

Press Releases

Items Per Page

Year

January 22, 2019

Revance Announces Closing of Public Offering of Common Stock

January 17, 2019

Revance Announces Pricing of Public Offering of Common Stock

January 15, 2019

Revance Announces Proposed Public Offering of Common Stock

January 15, 2019

Revance Announces Ground-Breaking Data Presentations at Leading International Neurotoxin Conference

January 7, 2019

Revance Highlights Recent Regulatory Progress and Provides Anticipated 2019 Milestones

December 4, 2018

Revance Announces China Market License Agreement with Fosun Pharma for RT002

December 4, 2018

Revance’s RT002 Demonstrates Unprecedented Efficacy and Duration In Largest-Ever Aesthetic Neuromodulator Clinical Program

November 20, 2018

Revance to Participate in Upcoming Investor Conferences

November 7, 2018

Revance to Participate in the Credit Suisse Healthcare Conference

November 1, 2018

Revance Releases Third Quarter 2018 Results

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Displaying 51 - 60 of 207

Investor Relations

Investor Relations
Press Releases
Events & Webcasts
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQs
Contact Us

image description

Revance - Shareholder Tools

Print Page
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Share
Search

Keep up with Revance

Subscribe

7555 Gateway Boulevard
Newark, California 94560

+1 (510) 742-3400

facebook
instagram
twitter
linkedin

Aesthetics

Overview
RHA®
HintMD
Neuromodulator
Neuromodulator Uses
Clinical Highlights

Therapeutics

Overview
Our Science
Muscle Movement Disorders
Pain Disorders
Clinical Highlights

Investors

Investor Relations
Press Releases
Events & Webcasts
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQ

Company

Overview
About Revance
Leadership Team
Board of Directors
Partnerships
Contact Revance
Contact Medical Affairs
Corporate Social Responsibility

News

All News
In the News
Our Latest

Careers

Overview
Career Opportunities
Culture
Benefits & Perks

© Copyright 2020
All Rights Reserved
Terms of Use
Privacy Policy

Facebook
LinkedIn